Mitigation of Antimicrobial Resistance (AMR) in G20




Antimicrobial resistance (AMR) is a recognised global threat to health security. However, mainstreaming responses to this threat into public policy has remained elusive, and anti-AMR measures have been limited to health interventions. AMR is caused by global factors, including sustained and irresponsible antibiotic use in humans and animals, as well as climate change. Hence its effective management also requires global collaborative efforts. This policy brief provides an overview of AMR, its significance, and the current landscape of policies, national action plans, and funding for AMR research and surveillance within the G20 countries. It also highlights the need for concerted action and international cooperation to address this critical issue.


Antimicrobial resistance, G20, Pandemic, NAPs


Download data is not yet available.

Authors Bio

Aniket Shevade, Takshashila Institution

Aniket Shevade is a Research Analyst at the Takshashila Institution

Shambhavi Naik, Takshashila Institution

Shambhavi Naik is the Head of Research at Takshashila and is the chairperson of the Advanced Biology programme.


Centers for Disease Control and Prevention n.d. Core Elements of Antibiotic Stewardship. Last accessed on July 19, 2023.

Chambers, Henry F and DeLeo, Frank R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009 Sep;7(9):629-41. doi: 10.1038/nrmicro2200. PMID: 19680247; PMCID: PMC2871281.

Charani, Esmita, Mendelson Mark, Pallet, Scott JC, Ahmad, Raheelah, Mpundu, Mirfin, Mbamalu Oluchi, Bonaconsa, Candice, Nampoothiri, Vrinda, Singh, Sanjeev, Peiffer-Smadja, Nathan et al. An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations. Health policy 2023: 11(3) E466 -E474.

Clift, Charles, 2019. The Global Governance of Antimicrobial Resistance. Chatham House.

FAO, UNEP WHO, and WOAH. 2022. Global Plan of Action on One Health. Towards a more comprehensive One Health, approach to global health threats at the human-animal-environment interface. Rome.

G20 Leader’s Declaration, 2017 Berlin Declaration of the G20 Health Ministers,

G20 Leader’s Declaration, 2020. G20 Bali Leader’s Declaration.,%2015-16%20November%202022.pdf

Global AMR R&D Hub (2021). Annual Report 2021: The Global AMR R&D Funding Landscape.

HM Government, 2019. Tackling antimicrobial resistance 2019–2024 The UK’s five-year national action plan.

Government of Kerala. 2018. Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP).

iGEM, n.d. Last accessed on July 19, 2023.

Innovative Medicines Initiative, n.d. Last accessed on July 19, 2023.

Klein, Eili. Y, Van Boeckel, Thomas P, Martinez, Elena M, Pant, Suraj, Gandra, Sumanth, Levin, Simon A, Goossens, Herman, & Laxminarayan, Ramanan. (2018). Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proceedings of the National Academy of Sciences, 115(15), E3463-E3470.

Lundsby, Katrine and Sönksen Ute Wolff. Working with One Health AMR in Denmark. Ministry of Food, Agriculture and Fisheries of Denmark/Statens Serum Institut.

Medicines Patent Pool, n.d. Last accessed on July 19, 2023.

Morgan, Daniel J, Okeke, Iruka N., Laxminarayan, R., Perencevich, Eli N, & Weisenberg, Scott A. (2011). Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect. Dis., 11(9), 692-701. doi:10.1016/S1473-3099(11)70054-8

Munkholm, L and Rubin, Olivier. 2020. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans. Global Health 16, 109 (2020).

Northern Dimension Partnership in Public Health and Social Well-Being n.d. Last accessed on July 19, 2023.

Nordmann, Patrice and Poirel, Laurent. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014 Sep;20(9):821-30. doi: 10.1111/1469-0691.12719. PMID: 24930781.

OECD, WHO, FAO and OIE, 2017. Tackling antimicrobial resistance ensuring sustainable R&D.

Patel, Jay, Harant, Anne, Fernandes, Genevie, Mwamelo, Ambele J, Hein, Wolfgang, Dekker, Denise and Sridhar Devi. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries. Lancet Infect Dis. 2023 Jun;23(6):706-718. doi: 10.1016/S1473-3099(22)00796-4. Epub 2023 Jan 16. PMID: 36657475.

Public Health Agency n.d. Last accessed on July 19,, 2023.

Public Health Agency of Canada, n.d. Federal action plan on antimicrobial resistance and use in Canada building on the federal framework for action.

Review on Antimicrobial Resistance. 2016. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. AMR Review, London.

Review on Antimicrobial Resistance. 2014 Tackling a Crisis for the Health and Wealth of Nations. AMR Review, London.

Seung, Kwonjune J, Keshavjee, Salmaan and Rich, Michael L. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863. doi: 10.1101/cshperspect.a017863. PMID: 25918181; PMCID: PMC4561400

Tacconelli, Evelina, Sifakis, Frangiscos, Harbarth Stephan, Schrijver Remco, van Mourik Maaike, Voss Andreas, Sharland Mike, Rajendran Nithya B and Rodríguez-Baño Jesús. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018 Mar;18(3):e99-e106. doi: 10.1016/S1473-3099(17)30485-1. Epub 2017 Nov 5. PMID: 29102325.

The Fleming Fund, n.d. Last accessed on July 19, 2023.

The Global Fund, n.d. Last accessed on July 19, 2023.

The Global Health Observatory, n.d. Last accessed on July 19, 2023.

The Indian Technical and Economic Cooperation Programme, n.d. Last accessed on July 19, 2023.

Unemo, Magnus and Shafer, William M. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. PMID: 24982323; PMCID: PMC4135894.

United States Government, 2020. Report to Congressional Committees FDA’s Priority Review Voucher Programs.

Willemsen Angela, Reid Simon and Assefa Yibeltal. A review of national action plans on antimicrobial resistance: strengths and weaknesses. Antimicrob Resist Infect Control. 2022 Jun 23;11(1):90. doi: 10.1186/s13756-022-01130-x. PMID: 35739564; PMCID: PMC9229779.

Wilson Lindsay A, Van Katwyk, Susan R, Weldon Issac and Hoffman, Steven J. A Global Pandemic Treaty Must Address Antimicrobial Resistance. The Journal of Law, Medicine & Ethics, 49 (2021): 688-691. P

World Bank. 2017. Drug-Resistant Infections: A Threat to Our Economic Future. Washington, DC: WorldBank.

World Health Organisation (2015). Argentina: Strategy for the control of antimicrobial resistance.

World Health Organisation, 2021. INDIA: A push to vaccinate every child, everywhere, ended polio in India. Last accessed on July 19th 2023.

World Health Organisation (2021a). Antimicrobial resistance: global report on surveillance. World Health Organization.

World Health Organisation (2021b). Comprehensive Review of the WHO Global Action Plan on Antimicrobial Resistance

World Health Organisation (2022a). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022.

World Health Organisation (2022b). Social determinants of health. EB152/22 152nd session 12 December 2022 Provisional agenda item 16.

World Health Organisation (2023). Accessed July 19th, 2023.

World Health Organisation, n.d. Accessed July 19th, 2023.